Table 2b.
Overview of studies reporting on endothelial cell health after anterior chamber iris-fixated phakic intraocular lens implantation
Nr. Eyes [Nr. pt] | Follow-up (mo) | Preop ACD (mm) | ECD (cells/mm²) | Total EC loss (%) | ||
---|---|---|---|---|---|---|
Preop | Postop | |||||
Artisan Myopia, Ophtec | ||||||
Budo, C., 2000[31] | 249 [NR] | 36 | 3.38‡ | 2876 | 2607 | NR† |
Pop, M., 2004[57] | 293 [NR] | 24 | NR | 2631 | 2577 | -0.8† |
Asano-Kato, N., 2005[33] | 11 [NR] | 24 | NR | 2831 | 2750 | NR† |
Coullet, J., 2006[35] | 31 [31] | 12 | NR | 2638 | 2473 | -9.4† |
Benedetti, S., 2007[58] | 49 [30] | 60 | NR | 2616 | 2379 | -9† |
Gierek-Ciaciura, S, 2007[37] | 20 [12] | 12 | 3.39‡ | 2651 | NR | -6.8† |
Moshirfar, M., 2007[38] | 38 [NR] | 24 | NR | 2713 | 2534 | -6.5† |
Tahzib, N.G., 2007[39] | 89 [49] | 60 | 3.30‡ | 2817 | 2734 | -3.3† |
Tahzib, N.G., 2007[39] | 89 [49] | 120 | 3.30‡ | 2817 | 2800 | -8.9† |
Guell, J. L., 2008[40] | 89 [NR] | 60 | NR | 2836 | 2514 | -11.3† |
Guell, J. L., 2008[40] | 165 [NR] | 60 | NR | 2755 | 2454 | -10.9† |
Silva, R.A., 2008[41] | 19 [NR] | 60 | 3.87* | 2481 | 2156 | -14.1† |
Stulting, R.D., 2008[42] | 386 [NR] | 36 | NR | NR | NR | -4.8† |
Yamaguchi, T., 2008[59] | 20 [11] | 12 | 3.66* | 3139 | 3023 | NR† |
Jonker, S.M., 2018[60] | 193 [NR] | 60 | 3.68* | 2670 | 2588 | -4.1 |
Jonker, S.M., 2018[60] | 127 [NR] | 120 | 3.68* | 2670 | 2302 | -11.5 |
Eldanasoury, A., 2019[61] | 90 [57] | 144 | 3.45* | 2645 | 1751 | -26.7 |
alvis, V., 2019[62] | 67 [45] | 114 | NR | NR | NR | -18.5 |
Shaaban, Y., 2020[63] | 20 [NR] | 36 | NR | 2707 | 2279 | -15.7† |
Artisan Hyperopia (Toric), Ophtec | ||||||
Guell, J. L., 2008[40] | 34 [NR] | 48 | NR | 2735 | 2560 | -6.4† |
Galvis, V., 2019[62] | 10 [5] | 108 | NR | NR | NR | -10.5 |
Artisan Toric, Ophtec (Mixed Groups) | ||||||
Dick, H. B., 2003[32] | 70 [NR] | 6 | 3.47* | 2983 | 2849 | -4.5† |
Guell, J. L., 2003[50] | 27 [16] | 12 | NR | 2649 | 2726 | 2.9† |
Guell, J. L., 2008[40] | 67 [NR] | 36 | NR | 2632 | 2537 | -3.6† |
Jonker, S.M., 2018[60] | 40 [NR] | 60 | 3.49* | 2695 | 2270 | -11.9 |
Jonker, S.M., 2018[60] | 20 [NR] | 120 | 3.49* | 2695 | 2009 | -18.5 |
Artiflex Myopia (Toric), Ophtec | ||||||
Coullet, J., 2006[35] | 31 [31] | 12 | NR | 2654 | 2405 | -9.0† |
Dick, H. B., 2009[51] | 290 [191] | 24 | 3.65* | 2634 | 2605 | -1.07† |
Doors, M., 2012[52] | 115 [73] | 6 | 3.65* | 2805 | 2676 | -4.3† |
Munoz, G., 2012[53] | 42 [25] | 12 | 3.51‡ | 2801 | 2538 | NR† |
Ozerturk, Y., 2012[54] | 50 [NR] | 24 | 3.41‡ | 3023 | 2797 | -7.4† |
Ruckhofer, J., 2012[55] | 42 [24] | 6 | NR | 2646 | 2627 | -0.7† |
Jonker, S.M., 2018[64] | 137 [NR] | 60 | 3.27* | 2739 | 2480 | -10.5[1] |
Jonker, S.M., 2018[64] | 63 [NR] | 60 | 3.24* | 2769 | 2488 | -10.2[1] |
Shaaban, Y., 2020[63] | 20 [NR] | 36 | NR | 2899 | 2173 | -25.0† |
Ghoreishi, M., 2020[56] | 41 [41] | 12 | NR | 2777 | 2721 | NR‡ |
Mo = Months; ACD = Anterior chamber depth; ECD = Endothelial cell density; EC = Endothelial cell; NR = Not reported. *as measured from the corneal epithelium, around 0.5 mm consists of corneal thickness, †measurement not repeatable based on materials and methods section, ‡measurement method not reported, 1chronic loss from 6 months to endpoint